Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 6/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | DRD3 | P35462 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12247772 | 1.00 | KMT2A (0.54) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL8775328 | 1.00 | KMT2A (0.54) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL12492369 | 0.94 | KMT2A (0.58) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL12492368 | 0.94 | KMT2A (0.58) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL3180013 | 0.86 | ACHE (0.43) | KMT2AMEN1OPRM1CYP2D6TSHR | |
| SCHEMBL27944944 | 0.84 | KMT2A (0.41) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL1190301 | 0.82 | KMT2A (0.50) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL1190299 | 0.82 | KMT2A (0.50) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL1189753 | 0.80 | KMT2A (0.61) | KMT2AMEN1EPHX2RIPK1DDB1 | |
| SCHEMBL5859687 | 0.79 | MEN1 (0.47) | KMT2AMEN1EPHX2DDB1CRBN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977346-B2 | Spiro compounds and methods of use | CHEN GUOQING PAUL | 2011-07-12 | — | — | US | disclosed |
| US-20070167470-A1 | Spiro compounds and methods of use | CHEN GUOQING P | 2007-07-19 | — | — | US | disclosed |
| EP-0529688-B1 | Azaspiro(n,m)alkanes and diazaspiro(n,m)-alkanes | DAIICHI SEIYAKU CO (JP) | 1997-11-12 | — | — | EP | disclosed |
| US-5508428-A | Spiro compound | DAIICHI PHAMACEUTICAL CO., LTD. (JP) | 1996-04-16 | — | — | US | disclosed |
| EP-0357047-B1 | Spiro compounds | DAIICHI SEIYAKU CO (JP) | 1993-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167470-A1 | Spiro compounds and methods of use | TEK, KDR, EGFR | KMT2A 4512/4885MEN1 1990/4885EPHX2 2159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.